This Friday, October 10, Isis Pharmaceuticals will be presenting results from their Phase II clinical trials of ISIS-SMNRx in both children and infants. The results will be presented as part of the 19th International World Muscle Society Congress in Berlin, Germany. The presentation is also available via a live streaming webcast and conference call.

When: Friday, October 10 at 11:30 am ET/8:30 am PT
Conference dial-in: 877.443.5662 or 412.902.6619 (international)
Webcast: Log onto

If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at

We’ll also be sharing a summary of the results, and other relevant updates from this meeting.